Delivery Order SPE2DB22D2006-SPE2DB25FV9BL
Award Date 3/12/25
Potential Completion Date 3/13/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,879.95 contract is to provide HAVRIX 1,440 unit/mL syringes, a hepatitis A vaccine. This order is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which allows for the supply of a wide range of...
- This is a $3,871.66 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract has an ultimate completion date of March 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a $20,172.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,429.28 firm-fixed-price contract is for the supply of HAVRIX 720 Unit/0.5 mL syringes, a hepatitis A vaccine. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,828.24, is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract is a firm fixed-price delivery order with a performance period through May 2, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set aside and was...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Havrix 720 Unit/0.5 ML Syringe 0.5ML. The contract has a ceiling value of $3,850.20 and a completion date of June 7, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
- This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,116.48 firm fixed-price contract is for the supply of HAVRIX 1,440 unit/mL syringes, a hepatitis A vaccine. The contract has a completion date of February 24, 2025 and was awarded on February 21, 2025. This IDC, valued at $999,999,999, serves as a primary vehicle for...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,069.00, is for the delivery of 1,440 unit/mL syringes of the hepatitis A vaccine Havrix. The contract has an ultimate completion date of April 23, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,097.60, is for the supply of Havrix 720 unit/0.5 mL syringes, a hepatitis A vaccine. The contract is a firm fixed-price, non-set-aside arrangement, with a performance period through April 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,333 units of the HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML vaccine, with a ceiling value of $6,073.20. The contract is not set-aside and has an ultimate completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...